Expert Review of Neurotherapeutics

Article	Citations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	56
The relevance of cortical thickness in migraine sufferers and implications to therapy	50
Steps to manage treatment-refractory migraine in adults	47
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	35
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	34
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	34
The latest developments with internet-based psychological treatments for depression	33
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	32
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	32
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	32
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	31
Where Art Thou O treatment for diabetic neuropathy: the sequel	31
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	30
Advances in the treatment and management of frontotemporal dementia	29
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	28
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	28
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	27
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications	26
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	26
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	25
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	25
Why is ADHD so difficult to diagnose in older adults?	25
Hesitancies in primary headaches treatments	25
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	24
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?	23

Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?	23
Advances in the early diagnosis of amyotrophic lateral sclerosis	23
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations	23
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	22
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	22
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	22
Preferences, tailoring, and self-tailoring in internet-delivered treatments: lessons learned	22
Spinal automaticity of movement control and its role in recovering function after spinal injury	21
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	21
Correction	21
Diagnostic advances and challenges in meningioma	20
Mindfulness as a therapeutic option for obsessive-compulsive disorder	20
The impact of sleep apnea on epilepsy treatment outcomes	19
Virtual reality technology in the treatment of anxiety – progress and future challenges	19
Multimodal approaches to the treatment of personality disorder	19
Current use of neurotoxins for alleviating symptoms of cervical dystonia	19
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	18
Navigating long-acting antipsychotic decision-making in schizophrenia: clinical considerations and best practices	18
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	18
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	18
Considerations for hormonal therapy in migraine patients: a critical review of current practice	17
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	17
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	17
Illuminating the way: the role of bright light therapy in the treatment of depression	17
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	16
Cognitive and motivational therapy for problematic alcohol use and alcohol use disorder in older adults: a systematic review	16
The differential diagnosis of autism spectrum disorder in adults	16
A novel treatment option for intrajejunal levodopa administration	16
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	16
Cross-national reflections on medicinal cannabis and depression	16
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	16
An overview of current and emerging strategies for phantom limb pain	15
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	15
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies	15
Frontotemporal dementia. How to deal with its diagnostic complexity?	15
Long-term outcomes in refractory status epilepticus	15
Daridorexant: exploring its role in the treatment of insomnia disorder	15
Considering hearing loss as a modifiable risk factor for dementia	15
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes	15
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor	14
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	14
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	14
Thymectomy in myasthenia gravis: timing and indications	14
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	13
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	13
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	13
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond	13
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	13
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	13
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	13

The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	13
Do people with bipolar disorder have a greater risk of dementia in later life?	13
An update on the developments and challenges with the diagnosis and classification of autoimmune optic neuritis	13
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	12
When and in what patient segments are low-intensity and remote interventions valuable for treating symptoms of post-concussion syndrome	12
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?	12
Developments in targeting calcitonin gene-related peptide	12
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	12
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	12
Could self-reporting sleep duration become an important tool in the prediction of dementia?	12
Therapeutic issues in Guillain–Barré syndrome	12
Bipolar disorder staging and the impact it has on its management: an update	11
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	11
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	11
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	11
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”	11
Stem cell therapy for patients with paraplegia: is there hope for the future?	11
Exploring the differential diagnosis of generalized diabetic peripheral neuropathy	11
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	11
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?	11
Understanding the genetic risk of schizophrenia	10
Rethinking the role of trazodone in the different depressive dimensions	10
Long-term central nervous system (CNS) consequences of COVID-19 in children	10
Contemporary perspectives in cerebral amyloid angiopathy	10
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	10
What place does daridorexant have in the treatment of Binge-Eating Disorder?	10
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome	10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	10
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	9
Learnings in developmental and epileptic encephalopathies: what do we know?	9
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	9
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	9
Treating the root cause of tension-type headache: when analgesics address the symptom but not the disorder	9
The major challenges with pharmacologic management of chronic traumatic encephalopathy	9
Tobacco use disorder and depression: emerging strategies and recommendations:	9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	9
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	9
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	9
The challenges and opportunities related to the therapeutic use of music in psychiatry	9
Is transcranial direct current stimulation a viable treatment option for fibromyalgia?	9
Deep brain stimulation: new programming algorithms and teleprogramming	9
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	9
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures	9
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	9
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	9
Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates: a plain language summary of publication	9
The value of radiotherapy in patients with recurrent atypical meningioma: an update	9
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy	8
An update on pharmacotherapy for trigeminal neuralgia	8
Contemporary diagnosis and treatment of conduct disorder in youth	8
Pharmacological strategies for treating social anxiety disorder in adults: a systematic review of studies published since 2015	8
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	8
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines	8
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	8
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	8
Current and emerging therapies for autoimmune encephalitis	8
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	8
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	8
Letter to the editor: reflections on the future of medical cannabis research for depression	8
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	8
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	7
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	7
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	7
Mobile health technologies for the management of Parkinson’s disease	7
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	7
The latest views on how vagus nerve stimulation works in epilepsy: a plain language summary	7
When is pharmacological intervention recommended for adults with social anxiety disorder?	7
Fremanezumab for migraine in clinical practice: a systematic review and meta-analysis	7
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	7
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	7
What impact can brain stimulation interventions have on borderline personality disorder?	7
Challenges in the treatment of dysthymia: a narrative review	7
Central vestibular dysfunction: don’t forget vestibular rehabilitation	7
Is it possible to prevent relapse in panic disorder?	7
An update on the comorbidity of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) and its clinical management	7
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	7
Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance	7
Pain relief but at what cost: the need for suicidality screening during chronic pain management	7
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	7

Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	7
Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?	7
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	7
Optimizing cognitive behavioral therapy to treat anxiety among youth with autism spectrum disorders	7
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	7
Can the integration of blood-based biomarkers into Alzheimer’s disease diagnosis revolutionize the field?	7
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	6
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	6
Centanafadine to treat ADHD in children and adolescents: a plain language summary of publication	6
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	6
Gene therapy for Parkinson’s disease: current landscape, translational challenges, and future directions	6
Paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury: the pathophysiological role of glutamate and potential treatment with branched-chain amino acids	6
Precision pain management: can delta opioid receptor (DOR) agonists outperform more traditional pain management strategies?	6
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	6
Assessing cognitive impairment among pediatric epilepsies: a systematic review	6
Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison	6
Speech and language outcome measures in clinical trials of Alzheimer’s and Parkinson’s diseases	6
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	6
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	6
Pharmacological options for narcolepsy: are they the way forward?	6
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	6
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	6
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	6
Multiomics and proteomic insights into Alzheimer’s disease biology in Down syndrome	6
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	6
Current perspectives on the diagnosis and management of acute transverse myelitis	5
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	5
The path to clinical application of human microglia transplantation for the treatment of CSF1R-related disorder	5
Rethinking the medication management of major depression	5
The utility of magnetoencephalography in epilepsy and its implications for treatment	5
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	5
Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway	5
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	5
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	5
Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson’s disease: a systematic review of chronic randomized controlled trials	5
New trends in the treatment of blepharospasm: replacing the standardized approach with a personalized approach	5
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	5
Delirium and dementia in the ICU - A neurocritical care perspective	5
Are ketamine and its enantiomers the answer to treatment-refractory depression?	5
Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage	5
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	5
Managing symptoms and improving the quality of life of persons with Machado-Joseph disease	5
Evaluating the adenosine hypothesis of restless legs syndrome and its implications for current and future treatment strategies	5
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	5
Adapting psychedelic medicine for headache and chronic pain disorders	5
Acute and prophylactic treatment of dialysis headache: a systematic review	5
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	5
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	4
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
Current options for the treatment of anxiety in adults with autism spectrum disorder	4
Current and emerging treatment options for Angelman syndrome	4
Centanafadine for the treatment of attention-deficit/hyperactivity disorder in adults: a plain language summary of publication	4
Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials	4
Redefining insomnia: from neural dysregulation to personalized therapeutics	4
Risk factors and disease associations in people living with idiopathic intracranial hypertension	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
Trichotillomania and its treatment: an updated review and recommendations	4
Essential tremor - drug treatments present and future	4
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndrome	4
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	4
Can pharmacotherapy help to reduce trichotillomania?	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
Withdrawal of antiseizure medications – for whom, when, and how?	4
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	4